Geode Capital Management LLC Sells 3,771 Shares of ZimVie Inc. (NASDAQ:ZIMV)

Geode Capital Management LLC decreased its stake in ZimVie Inc. (NASDAQ:ZIMV) by 0.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 642,793 shares of the company’s stock after selling 3,771 shares during the quarter. Geode Capital Management LLC owned approximately 2.33% of ZimVie worth $8,969,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. SG Americas Securities LLC increased its holdings in ZimVie by 15.7% in the 4th quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock worth $155,000 after acquiring an additional 1,508 shares in the last quarter. EMC Capital Management increased its stake in shares of ZimVie by 47.0% in the fourth quarter. EMC Capital Management now owns 13,802 shares of the company’s stock worth $193,000 after purchasing an additional 4,414 shares in the last quarter. Principal Financial Group Inc. purchased a new stake in shares of ZimVie in the third quarter worth $275,000. Bailard Inc. raised its position in shares of ZimVie by 35.0% during the 4th quarter. Bailard Inc. now owns 21,194 shares of the company’s stock valued at $296,000 after purchasing an additional 5,494 shares during the period. Finally, Fox Run Management L.L.C. purchased a new position in shares of ZimVie during the 4th quarter valued at $463,000. 95.63% of the stock is owned by hedge funds and other institutional investors.

ZimVie Price Performance

ZIMV stock opened at $9.38 on Thursday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. The company’s fifty day moving average price is $11.31 and its 200-day moving average price is $13.15. ZimVie Inc. has a one year low of $8.56 and a one year high of $22.40. The company has a market capitalization of $261.20 million, a PE ratio of -0.72 and a beta of 2.14.

ZimVie (NASDAQ:ZIMV) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.25 by $0.02. The business had revenue of $111.52 million for the quarter, compared to analysts’ expectations of $113.67 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. On average, equities analysts anticipate that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have commented on ZIMV shares. Needham & Company LLC reissued a “hold” rating on shares of ZimVie in a report on Wednesday, April 9th. B. Riley assumed coverage on ZimVie in a research note on Thursday, April 10th. They set a “buy” rating and a $16.00 target price on the stock.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.